Clinical Trials for Latent Tuberculosis

Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda

NCT ID: NCT06751706

Training Protocol on the Natural History of Tuberculosis

NCT ID: NCT01212003

This clinical trial is focused on understanding tuberculosis (TB), an infectious disease that affects many people around the world. The researchers want to learn more about how TB develops and prog...

Economic Incentives and vDOT for Latent Tuberculosis Infection

NCT ID: NCT05022862

This clinical trial is studying a new way to help people complete their treatment for latent tuberculosis (TB), which is when a person is infected with TB but does not have symptoms or spread the d...

TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts

NCT ID: NCT06022146

The TB YOUTH trial is a study looking at a new way to treat latent tuberculosis (LTBI) in students who may have been exposed to someone with active tuberculosis (TB) in their school. The researcher...

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

NCT ID: NCT05411744

This clinical trial is looking at a one-month treatment plan for people who have latent tuberculosis (TB) and are candidates for kidney transplants. The researchers want to learn how safe the treat...

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

NCT ID: NCT06526689

This clinical trial is studying how the body’s immune system in the lungs reacts to tuberculosis (TB) after someone has been recently exposed to the bacteria that cause the disease. Researchers wan...

Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention

NCT ID: NCT06281834

This clinical trial is studying how well the medications dolutegravir, rifapentine, and isoniazid work together in children who are living with HIV and have latent tuberculosis (TB) infection. Late...

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

NCT ID: NCT03474029

This clinical trial is studying a new treatment for people with latent tuberculosis infection (LTBI), which is when someone has the bacteria that causes tuberculosis (TB) in their body but does not...

Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

NCT ID: NCT05073926

This clinical trial is studying the effects of two different treatments for latent tuberculosis (a type of TB that doesn't cause symptoms but can become active later). The researchers want to find ...

New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis

NCT ID: NCT05621343

This clinical trial is looking at new ways to identify if people with latent tuberculosis (TB) still have live bacteria in their bodies. Currently, some tests can’t tell the difference between thos...

Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease

NCT ID: NCT05021731

This clinical trial is looking at different treatment options for latent tuberculosis (TB) in patients who have end-stage kidney disease, a serious condition where the kidneys can no longer functio...

Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students

NCT ID: NCT05756582

This clinical trial is looking at how common Latent Tuberculosis Infection (LTBI) is among health care workers and students at a hospital in Rome. LTBI means that a person has been infected with th...

Comorbidities and Coinfections in Latent TB

NCT ID: NCT04642755

This clinical trial is studying how certain health conditions, like diabetes, malnutrition, and infections from worms (helminths), affect people who have latent tuberculosis (LTBI). LTBI means that...